Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Goetz

Showing results (121-130 of 265) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2023
Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast CancerGary N Schwartz, Peter A Kaufman, Karthik V Giridhar, et al.
AJR. American Journal of Roentgenology|June 6, 2019
Comparison of <sup>99m</sup>Tc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant ChemotherapyKatie N Hunt, Amy Lynn Conners, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006Mothaffar F Rimawi, Ingrid A Mayer, Andres Forero, et al.
Clinical Pharmacology and Therapeutics|May 28, 2021
Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast CancerJunmei Cairns, Krishna R Kalari, James N Ingle, et al.
Cancer Research|May 21, 2021
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N Kohale, Danielle M Burgenske, Ann C Mladek, et al.
Radiology|October 24, 2006
Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysisMatthew R Callstrom, Thomas D Atwell, J William Charboneau, et al.
JCO Clinical Cancer Informatics|January 18, 2019
PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual PatientKrishna R Kalari, Jason P Sinnwell, Kevin J Thompson, et al.
Breast Cancer Research and Treatment|September 18, 2017
Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008Roisin M Connolly, Mary Jo Fackler, Zhe Zhang, et al.
Cancer|May 12, 2017
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinomaRobert R McWilliams, Nathan R Foster, Michelle R Mahoney, et al.
Breast Cancer Research and Treatment|January 11, 2015
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2Celine M Vachon, Daniel J Schaid, James N Ingle, et al.
Pageof 27

Showing results (121-130 of 265) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2023
Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast CancerGary N Schwartz, Peter A Kaufman, Karthik V Giridhar, et al.
AJR. American Journal of Roentgenology|June 6, 2019
Comparison of <sup>99m</sup>Tc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant ChemotherapyKatie N Hunt, Amy Lynn Conners, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006Mothaffar F Rimawi, Ingrid A Mayer, Andres Forero, et al.
Clinical Pharmacology and Therapeutics|May 28, 2021
Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast CancerJunmei Cairns, Krishna R Kalari, James N Ingle, et al.
Cancer Research|May 21, 2021
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N Kohale, Danielle M Burgenske, Ann C Mladek, et al.
Radiology|October 24, 2006
Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysisMatthew R Callstrom, Thomas D Atwell, J William Charboneau, et al.
JCO Clinical Cancer Informatics|January 18, 2019
PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual PatientKrishna R Kalari, Jason P Sinnwell, Kevin J Thompson, et al.
Breast Cancer Research and Treatment|September 18, 2017
Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008Roisin M Connolly, Mary Jo Fackler, Zhe Zhang, et al.
Cancer|May 12, 2017
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinomaRobert R McWilliams, Nathan R Foster, Michelle R Mahoney, et al.
Breast Cancer Research and Treatment|January 11, 2015
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2Celine M Vachon, Daniel J Schaid, James N Ingle, et al.
Pageof 27